May 05, 2020 – Medicinal Genomics to Launch Medical Practicum at CannMed 2020 The biggest barrier to using medicinal cannabis is that the endocannabinoid system and its related pathologies are not taught in medical school, and as a result, physicians cannot help their patients use cannabis as an effective and safe medication

April 2, 2020 – Medicinal Genomics to Donate a Portion of CannMed Tickets Sales to COVID-19 Response Premier medical & scientific cannabis conference to contribute 10% of ticket sales to support CDC Emergency Response Fund to help mitigate the public health threat

March 10, 2020 – Medicinal Genomics Signs on as Agilent US Value Added Reseller MGC will sell Agilent’s Aria qPCR instruments and Bravo, Agilent’s liquid handling DNA purification and lab automation platform in the U.S


April 6, 2020 – Cannabis and Coronavirus: Help Keeps Coming from Industry BusinessesMedicinal Genomics Corp. (MGC) has pledged proceeds from ticket sales for its CannMed 2020 tradeshow, will be donated to pandemic relief.

March 3, 2020 – Pharmaceutical company claims to have developed a cannabis treatment for coronavirus symptomsKevin McKernan, founder of Massachusetts-based life sciences company, Medicinal Genomics, tweeted, “Bummer. There is actually some exciting preliminary work on cannabinoids and viruses that are now getting sold before it’s (…) understood.”

January 29, 2020 – Arbor Biosciences, Biosearch Technologies Ink Global Distribution Deal for Ag-Bio NGS PanelsOver the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.